IDEAYA Biosciences to Participate in Investor Conferences in February 2022
- Tuesday, February 1, 2022, 6:15
- Finance
- Add a comment
SOUTH SAN FRANCISCO, Calif., Feb. 1, 2022 /PRNewswire/ — IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in an investor conference…
About the Author
adminasapcorp has written 41268 stories on this site.